Moreover, not all reports show a direct correlation between IGF2 expression and DMR0 methylation changes at this locus and we have reported exceptions in breast cancer (Ito et al. submitted), while others have reported exceptions in ovarian and bladder cancer [28], [29]. This evidence concerns the gene IGF2 and urinary bladder cancer.